This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BackgroundProteinuria is a risk factor for cardiovascular events, but its prognostic value for sudden cardiacarrest (SCA) in young individuals remains unproven. Main outcome was SCA identified byInternational Classification of Diseases, Tenth Revision (ICD10).Participants The mean age was 30.95.0
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. AN evaluation of efficacy amonGst cOmpression only and standard CPR) trial is designed to evaluate whether compression-only cardiopulmonary resuscitation (CPR) by trained laypersons is noninferior to standard CPR in adult out-of-hospital cardiacarrest.
BackgroundOutofhospital cardiacarrest (OHCA) with initial shockable rhythm generally has a favorable prognosis. The primary outcome was rhythm conversion to nonshockable on hospital arrival. Journal of the American Heart Association, Ahead of Print.
Background:Different from the negative impact of COVID-19 pandemic on outcomes after out-of-hospital cardiacarrest (OHCA) collapsed before emergency medical service (EMS) arrival, there was a report suggested that COVID-19 pandemic did not affect outcomes after OHCA witnessed by EMS personnel. to 0.08; p = 0.21).
IMPRESSION: The finding of sinus bradycardia with 1st-degree AV block + marked sinus arrhythmia + the change in PR interval from beat #5-to-beat #6 — suggests a form of vagotonic block ( See My Comment in the October 9, 2020 post in Dr. Smith's ECG Blog ).
We aimed to investigate the prevalence and outcomes of patients with SMuRF-less ACS undergoing percutaneous coronary intervention (PCI) compared with those with SMuRFs. The primary outcome was 30-day mortality. Secondary outcomes included in-hospital and 30-day events. Patients with coronary artery disease were excluded.
BACKGROUND:The aim of this study was to examine the impact of early versus delayed catheter-based therapies (CBTs) on clinical outcomes in patients with acute intermediate-risk pulmonary embolism (PE).METHODS:This Secondary outcomes included a composite of 30-day mortality, resuscitated cardiacarrest, and hemodynamic instability.
Two recent interventions have proven in randomized trials to improve neurologic survival in cardiacarrest: 1) the combination of the ResQPod and the ResQPump (suction device for compression-decompression CPR -- Lancet 2011 ) and 2) Dual Sequential defibrillation. So, your next step is to Trace it down, and Copy it over".
As heart failure with preserved ejection fraction (HFpEF) comprises half of all heart failure cases, understanding its management and effect on outcomes is crucial. p=0.35) and cardiacarrest (aOR 1.05, 95% CI 0.8 - 1.36, p=0.74) in patients on chronic opioids. adjusted odds ratio [aOR] 1.01, 95% CI 0.85 - 1.2,
Outcome: 100% LAD Occlusion Here the Queen explains why: The dark blue tells us that she is looking especially at the QRS in V3 and the T-wave in V2 and V3. Not OMI, and we (Pendell and I) always take proportionality into account. So we taught the Queen on cases with very low voltage that were OMI.
Understanding the association with acute myocarditis (AMC) is crucial for preemptive management strategies and improving patient outcomes.Methods:We identified and compared adults (>18 years) with SID vs. non-SID patients hospitalized with AMC using the National In-patient sample database from 2016-2020.
Aims To describe the use and the relation to outcome of different ventilation strategies in a contemporary, large, prospective registry of cardiogenic shock patients. for the NIV group ( p =0.005), even after excluding patients with cardiacarrest at presentation. The 60-day mortality rates were 40.2%
Abstract Aims This study aimed to give contemporary insight into the use of Impella and venoarterial extracorporeal membrane oxygenation (VA-ECMO) in acute myocardial infarction-related cardiogenic shock (AMICS) and into associated outcomes, adverse events, and resource demands. Overall, adverse event rates and resource consumption were high.
They had had twice the rate of cardiacarrest and twice the in-hospital mortality[1] In another study of patients diagnosed with STEMI, those on dialysis experienced delayed reperfusion and double the mortality.[2] They were less likely to have STEMI on ECG, and more likely to be initially diagnosed as non-ACS. Circulation 2007 2.
But until that point, no one could have known his neurologic outcome, and the stated reason for not accepting was not worry for neurologic outcome but that the ECG did not meet STEMI criteria. The outcome measure was whether the patient ultimately had an OMI or not. A mysterious case.
It is apparently fortunate that she had a cardiacarrest; otherwise, her ECG would have been ignored. Then they did an MRI: Patient underwent cardiac MRI on 10/4 that showed mildly reduced BiV systolic function. She was defibrillated and resuscitated. Smith: this ECG and clinical presentation is diagnostic of LAD Occlusion.
A patient had a cardiacarrest with ventricular fibrillation and was successfully defibrillated. A reliable study would keep track of all patients with shockable arrest and analyze the ones who were not enrolled to see their outcomes. This is FAR LESS than all other studies of shockable arrest.
Cardiac Troponin Testing in Patients with COVID-19: A Strategy for Testing and Reporting Results. Clin Chem [Internet] 2020;Available from: [link] Smith mini-review: Troponin in Emergency Department COVID patients Cardiac Troponin (cTn) is a nonspecific marker of myocardial injury. 3–8 Shi et al. Guo T, Fan Y, Chen M, et al.
Background Research has described differences in the provision of prehospital treatment for women who experience out-of-hospital cardiacarrest. However, studies have reported conflicting results regarding survival outcomes or in-hospital interventions between sexes.
BackgroundPediatric out‐of‐hospital cardiacarrest (POHCA) is associated with significant mortality and poor neurological outcomes. The case group included children (aged 1 day to 17 years) who experienced an out‐of‐hospital cardiacarrest between 2004 and 2020.
Graphical abstract depicting cardiacarrest mortality disparities in the young, temporal trends, and its correlation with the social vulnerability index. Abstract Background Cardiacarrest (CA) is a leading cause of death in the United States (US). Social determinants of health may impact CA outcomes.
BackgroundInhospital cardiacarrest (IHCA) is associated with significant morbidity and mortality. The primary outcome was inhospital mortality. Secondary outcomes included rates of inhospital procedures. Journal of the American Heart Association, Volume 14, Issue 4 , February 18, 2025.
However, the association of socioeconomic vulnerability and outcomes after hospitalization is uncertain.Methods and ResultsAmerican Heart Association COVID19 Cardiovascular Disease Registry hospitalizations between March 1, 2020, and June 30, 2022, linked with Medicare feeforservice claims, were analyzed.
Nevertheless, the benefit of MP for postoperative clinical outcomes is controversial, especially in neonates. This study aimed to evaluate the effect of MP on postoperative inflammation and outcomes in neonatal cardiac surgery with cardiopulmonary bypass (CPB).Methods:From
Join us as we examine the landmark approvals that are revolutionizing patient outcomes. Notes: Approved after initial rejection two years prior based on safety data from Japan, where the drug had been used since 2020 It can only be used in kidney disease patients on dialysis for at least 3 months.
But the full cohort of the CABANA trial did not show a significant reduction in the primary composite end point of death, disabling stroke, serious bleeding or cardiacarrest [7]. 2020 Oct 1;383(14):1305-1316. Epub 2020 Aug 29. The study was stopped for efficacy at the third interim analysis after a median of 5.1
5 Over my career as a cardiovascular surgeon, as well as an immunologist, I have witnessed how current treatments for ASCVD have led to considerable improvements in outcomes, yet many patients remain vulnerable to life-threatening cardiac events.1,6 2020 Jan 28;141(4):e60] [published correction appears in Circulation.
About two hours after admission, he suffered a cardiacarrest (whether it was VF/VT or PEA is not available) and expired. Could this outcome have been prevented with emergent cath? And a complication. == MY Comment by K EN G RAUER, MD ( 10/11/2020 ): == It cannot be stated any clearer than what Dr. Meyers states above.
Smith comment: The patient was lucky to have a cardiacarrest. By undergoing an arrest, providers became aware of his OMI which had not been noticed on his diagnostic ECG, and he thus has a chance at some myocardial salvage. Had he not had one, he would have sat in the waiting room until his entire myocardium at risk infarcted.
2] Curiously, ACLS does not include consideration of calcium in its bradycardia algorithm, which could have prevented the arrest and which along with the epi produced ROSC. HyperKalemia with CardiacArrest. Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference.
Researchers analyze primary and secondary cardiovascular outcomes in 132,784 inpatients with COVID-19 (October 8, 2020 to September 30, 2021) and 31,173 inpatients with non-COVID-19 pneumonia (January 1, 2019 to December 31, 2019) in Korea. The results indicate a lower risk of cardiovascular disease in COVID-19 patients.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content